Glutamate excitotoxicity inflicts paranodal myelin splitting and retraction

PLoS ONE

Volumn 4, Issue 8, 2009, Pages

  Fu, Yan ^a   Sun, Wenjing ^b   Shi, Yunzhou ^a   Shi, Riyi ^a,b   Cheng, Ji Xin ^a,c  

^a PURDUE UNIVERSITY   (United States)

^b PURDUE UNIVERSITY   (United States)

^c PURDUE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOPYRIDINE; CALCIUM ION; CALCIUM IONOPHORE; CALPASTATIN; GLUTAMATE RECEPTOR AGONIST; GLUTAMATE RECEPTOR ANTAGONIST; GLUTAMIC ACID; KAINIC ACID RECEPTOR; MYELIN BASIC PROTEIN; N METHYL DEXTRO ASPARTIC ACID; POTASSIUM CHANNEL BLOCKING AGENT; POTASSIUM CHANNEL KV1.2; CALCIMYCIN; GLUTAMIC ACID DERIVATIVE;

ACTION POTENTIAL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AXONAL INJURY; CALCIUM TRANSPORT; CONTROLLED STUDY; EXCITOTOXICITY; INTERNODE; MICROSCOPY; MOLECULAR IMAGING; MYELIN SHEATH; NERVE CONDUCTION; NONHUMAN; QUANTITATIVE ANALYSIS; RAT; SPINAL CORD; TEMPERATURE; TISSUE STRUCTURE; WHITE MATTER; ANIMAL; DRUG EFFECT; FEMALE; GUINEA PIG; IMMUNOHISTOCHEMISTRY; LONG EVANS RAT; METABOLISM; RAMAN SPECTROMETRY; TRANSMISSION ELECTRON MICROSCOPY;

ANIMALS; CALCIMYCIN; FEMALE; GLUTAMATES; GUINEA PIGS; IMMUNOHISTOCHEMISTRY; MICROSCOPY, ELECTRON, TRANSMISSION; MYELIN SHEATH; RATS; RATS, LONG-EVANS; SPECTRUM ANALYSIS, RAMAN; SPINAL CORD;

EID: 69249096677     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0006705     Document Type: Article

References (56)

1. Stys PK (2004) White matter injury mechanisms. Curr Mol Med 4: 113-130.
2. Rothman SM, Olney JW (1986) Glutamate and the pathophysiology of hypoxic-ischemic brain damage. Ann Neurol 19: 105-111.
3. Werner P, Pitt D, Raine CS (2001) Multiple sclerosis: altered glutamate homeostasis in lesions correlates with oligodendrocyte and axonal damage. Ann Neurol 50: 169-180.
4. Park E, Velumian AA, Fehlings MG (2004) The role of excitotoxicity in secondary mechanisms of spinal cord injury: a review with an emphasis on the implications for white matter degeneration. J Neurotrauma 21: 754-774.
5. Waxman SG, Black JA, Stys PK, Ransom BR (1992) Ultrastructural concomitants of anoxic injury and early post anoxic recovery in rat optic nerve. Brain Res 574: 105-119.
6. 2+ - medicated injury in myelinated CNS axons. Brain Res 644: 197-204.
7. Howell OW, Palser A, Polito A, Melrose S, Zonta B, et al. (2006) Disruption of neurofascin localization reveals early changes preceding demyelination and remyelination in multiple sclerosis. Brain 129: 3173-3185.
8. Platt SR (2007) The role of glutamate in central nervous system health and disease - A review. Vet J 173: 278-286.
9. Matute C, Alberdi E, Domercq M, Sánchez-Gómez M-V, Pérez-Samartín A, et al. (2007) Excitotoxic damage to white matter. J Anat 210: 693-702.
10. Hulsebosch CE (2002) Recent advances in pathophysiology and treatment of spinal cord injury. Adv Physiol Educ 26: 238-255.
11. Matute C, Sánchez-Gómez MV, Martínez-Millán L, Miled R (1997) Glutamate receptor-mediated toxicity in optic nerve oligodendrocytes. Proc Natl Acad Sci USA 94: 8830-8835.
12. McDonald JW, Althomsons SP, Hyrc KL, Choi DW, Goldberg MP (1998) Oligodendrocytes from forebrain are highly vulnerable to AMPA/kainate receptor-mediated excitotoxicity. Nat Med 4: 291-297.
13. Li S, Stys PK (2000) Mechanisms of ionotropic glutamate receptor-mediated excitotoxicity in isolated spinal cord white matter. J Neurosci 20: 1190-1198.
14. Tekkök SB, Goldberg MP (2001) AMPA/kainate receptor activation mediates hypoxic oligodendrocyte death and axonal injury in cerebral white matter. J Neurosci 21: 4237-4248.
15. Cheng JX (2007) Coherent anti-Stokes Raman scattering microscopy. Appl Spectrosc 61: 197A-208A.
16. Morell P, Quarles RH (1999) Myelin formation, structure, and biochemistry. In: Siegel GJ, Agranoff BW, Alberts RW, Molinoff PB, eds (1999) Basic neurochemistry: molecular, cellular, and medical aspects. 5th ed. Philadelphia: Lippincott Williams & Wilkins.
17. Wang H, Fu Y, Zickmund P, Shi R, Cheng JX (2005) Coherent anti-Stokes Raman scattering imaging of live spinal tissues. Biophys J 89: 581-591.
18. Fu Y, Wang H, Huff TB, Shi R, Cheng JX (2007) Coherent anti-Stokes Raman scattering imaging of myelin degradation reveals a calcium dependent pathway in lyso-PtdCho induced demyelination. J Neurosci Res 85: 2870-2881.
19. Shi R, Borgens RB, Blight AR (1999) Functional reconnection of severed mammalian spinal cord axons with polyethylene glycol. J Neurotrauma 16: 727-738.
20. Matsuo A, Lee GC, Terai K, Takami K, Hickey WF, et al. (1997) Unmasking of an unusual myelin basic protein epitope during the process of myelin degeneration in humans: a potential mechanism for the generation of autoantigens. Am J Pathol 150: 1253-1266.
21. Stys PK, Waxman SG, Ransom BR (1992) Effects of temperature on evoked electrical activity and anoxic injury in CNS white matter. J Cereb Blood Flow Metab 12: 977-986.
22. 2+ exchange in spinal cord white matter injury at physiological temperature. J Neurophysiol 84: 1116-1119.
23. Black JA, Kocsis JD, Waxman SG (1990) Ion channel organization of the myelinated fiber. Trends Neurosci 13: 48-54.
24. + channels in terminal and juxtaparanodal regions of neurons. Nature 365: 75-79.
25. + channel complexes. J Neurosci 17: 8246-8258.
26. Poliak S, Peles E (2003) The local differentiation of myelinated axons at nodes of Ranvier. Nat Rev Neurosci 4: 968-980.
27. Luo J, Li N, Robinson JP, Shi R (2002) The increase of reactive oxygen species and their inhibition in an isolated guinea pig spinal cord compression model. Spinal Cord 40: 656-665.
28. Hayes KC (2004) The use of 4-aminopyridine (fampridine) in demyelinating disorders. CNS Drug Rev 10: 295-316.
29. Shi R, Kelly TM, Blight AR (1997) Conduction block in acute and chronic spinal cord injury: different dose-response characteristics for reversal by 4-aminopyridine. Exp Neurol 148: 495-501.
30. Jensen MJ, Shi R (2003) Effects of 4-aminopyridine on stretched mammalian spinal cord: the role of potassium channels in axonal conduction. J Neurophysiol 90: 2334-2340.
31. Bever CTJ (1995) 4-Aminopyridine: use in multiple sclerosis. CNS Drug Rev 1: 261-279.
32. 2+ permeability in recombinant glutamate receptor subtypes. J Physiol 538: 25-39.
33. Schaecher KE, Shields DC, Banik NL (2001) Mechanism of myelin breakdown in Experimental demyelination: a putative role for calpain. Neurochem Res 26: 731-737.
34. Káradóttir R, Cavelier P, Bergersen LH, Attwell D (2005) NMDA receptors are expressed in oligodendrocytes and activated in ischemia. Nature 438: 1162-1166.
35. Salter MG, Fern R (2005) NMDA receptors are expressed in developing oligodendrocyte processes and mediate injury. Nature 438: 1167-1171.
36. Micu I, Jiang Q, Coderre E, Ridsdale A, Zhang L, et al. (2006) NMDA receptors mediate calcium accumulation in myelin during chemical ischemia. Nature 439: 988-992.
37. Baltan S, Besancon EF, Mbow B, Ye ZC, Hammer MA, et al. (2008) White matter vulnerability to ischemic injury increases with age because of enhanced excitotoxicity. J Neurosci 28: 1479-1489.
38. McCarran WJ, Goldberg MP (2007) White matter axon vulnerablity to AMPA/ kainate receptor-mediated ischemic injury is developmentally regulated. J Neurosci 27: 4220-4229.
39. Fu Y, Wang H, Shi R, Cheng JX (2007) Second harmonic and sum frequency generation imaging of fibrous astroglial filaments in ex vivo spinal tissues. Biophys J 92: 3251-3259.
40. Mark LP, Prost RW, Ulmer JL, Smith MM, Daniels DL, et al. (2001) Pictorial review of glutamate excitotoxicity: fundamental concepts for neuroimaging. Am J Neuroradiol 22: 1813-1824.
41. Srinivasan R, Sailasuta N, Hurd R, Nelson S, Pelletier D (2005) Evidence of elevated glutamate in multiple sclerosis using magnetic resonance spectroscopy at 3T. Brain 128: 1016-1025.
42. Pitt D, Werner P, Raine CS (2000) Glutamate excitotoxicity in a model of multiple sclerosis. Nat Med 6: 67-70.
43. Smith T, Groom A, Zhu B, Turski L (2000) Autoimmune encephalomyelitis ameliorated by AMPA antagonists. Nat Med 6: 62-66.
44. Choi DW, Maulucci-Gedde M, Kriegstein AR (1987) Glutamate neurotoxicity in cortical cell culture. J Neurosci 7: 357-368.
45. Lipton SA, Rosenberg PA (1994) Excitatory amino acids as a final common pathway for neurologic disorders. New Engl J Med 330: 613-622.
46. Tekkök SB, Ye Z, Ransom BR (2007) Excitotoxic mechanisms of ischemic injury in myelinated white matter. J Cereb Blood Flow Metab 27: 1540-1552.
47. Yam PS, Dunn LT, Graham DI, Dewar D, M J (2000) NMDA receptor blockade fails to alter axonal injury in focal cerebral ischemia. J Cereb Blood Flow Metab 20: 772-779.
48. Matute C (2006) Oligodendrocyte NMDA receptors: a novel therapeutic target. Trends Mol Med 12: 289-292.
49. Schäbitz WR, Li F, Fisher M (2000) The N-methyl-D-aspartate antagonist CNS 1102 protects cerebral gray and white matter from ischemic injury following temporary focal ischemia in rats. Stroke 31: 1709-1714.
50. Brand-Schieber E, Werner P (2003) AMPA/Kainate receptors in mouse spinal cord cell-specific display of receptor subunits by oligodendrocytes and astrocytes and at the node of Ranvier. Glia 42: 12-24.
51. Banik NL (1992) Pathogenesis of myelin breakdown in demyelinating diseases: role of proteolytic enzymes. Crit Rev Neurobiol 6: 257-271.
52. Ray SK, Matzelle DD, Sribnick EA, Guyton MK, Wingrave JM, et al. (2003) Calpain inhibitor prevented apoptosis and maintained transcription of proteolipid protein and myelin basic protein genes in rat spinal cord injury. J Chem Neuroanat 26: 119-224.
53. Shields DC, Tyor WR, Deibler GE, Hogan EL, Banik NL (1998) Increased calpain expression in activated glial and inflammatory cells in experimental allergic encephalomyelitis. Proc Natl Acad Sci USA 95: 5768-5772.
54. Tait S, Gunn-Moore F, Collinson JM, Huang J, Lubetzki C, et al. (2000) An oligodendrocyte cell adhesion molecule at the site of assembly of the paranodal axo-glial junction. J Cell Biol 150: 657-666.
55. Charles P, Tait S, Faivre-Sarrailh C, Barbin G, Gunn-Moore F, et al. (2002) Neurofascin is a glial receptor for the paranodin/caspr-contactin axonal complex at the axoglial junction. Curr Biol 12: 217-220.
56. Huff TB, Cheng JX (2007) In vivo coherent anti-Stokes Raman scattering imaging of sciatic nerve tissue. J Microsc 225: 175-182.